Sionna Therapeutics, Inc. (SION) Insider Trading Disclosures
Sionna Therapeutics, Inc. (SION) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: SION
CIK: 2036042
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche LLP
Auditor SinceSince 12/31/2023 12:00:00 AM
Lead Engagement PartnerKevin Gauthier
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13D/A | 2026-09-21 | — | SCHEDULE 13D/A Filing | 0001346824-26-000239 | View SEC Doc Filr Page |
| 4 | 2026-09-21 | 2026-09-17 | 4 Filing | 0001231919-26-001201 | View SEC Doc Filr Page |
| 4 | 2026-09-18 | 2026-09-17 | PRIMARY DOCUMENT | 0001772518-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-09-18 | 2026-09-17 | PRIMARY DOCUMENT | 0002046433-26-000005 | View SEC Doc Filr Page |
| 4 | 2026-09-18 | 2026-09-17 | PRIMARY DOCUMENT | 0002061851-26-000009 | View SEC Doc Filr Page |
| 4 | 2026-09-18 | 2026-09-17 | PRIMARY DOCUMENT | 0001704336-26-000005 | View SEC Doc Filr Page |
| 144 | 2026-09-17 | — | 144 Filing | 0001315082-26-000002 | View SEC Doc Filr Page |
| 8-K | 2026-09-14 | 2026-09-09 | 8-K | 0001193125-26-390577 | View SEC Doc Filr Page |
| 8-K | 2026-08-10 | 2026-08-10 | 8-K | 0001193125-26-341230 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001628280-26-053839 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | 8-K | 0001628280-26-053832 | View SEC Doc Filr Page |
| 4 | 2026-07-09 | 2026-07-07 | 4 Filing | 0000947871-26-000695 | View SEC Doc Filr Page |
| 4 | 2026-07-09 | 2026-07-07 | 4 Filing | 0000947871-26-000694 | View SEC Doc Filr Page |
| 4 | 2026-07-07 | 2026-07-06 | PRIMARY DOCUMENT | 0002061851-26-000006 | View SEC Doc Filr Page |
| 144 | 2026-07-06 | — | 144 Filing | 0001950047-26-006887 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-06-30 | 4 Filing | 0000947871-26-000684 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-06-30 | 4 Filing | 0000947871-26-000683 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-17 | PRIMARY DOCUMENT | 0001644348-26-000007 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-17 | PRIMARY DOCUMENT | 0001816744-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-17 | PRIMARY DOCUMENT | 0001357522-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-17 | 4 Filing | 0001231919-26-000674 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-17 | PRIMARY DOCUMENT | 0002023849-26-000010 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-17 | PRIMARY DOCUMENT | 0001690959-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-17 | PRIMARY DOCUMENT | 0001857250-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-17 | PRIMARY DOCUMENT | 0001409601-26-000010 | View SEC Doc Filr Page |